Search the Health Library
Get the facts on diseases, conditions, tests and procedures.
I Want To...
I Want To...
Find Research Faculty
Enter the last name, specialty or keyword for your search below.
John H Fetting, M.D.
Associate Director for Clinical Practice
Associate Professor of Oncology
Expertise: Breast Cancer, Medical Oncology
Research Interests: Breast Cancer
Request an Appointment
I live in Maryland
Request an appointment through My
I live outside of Maryland
I live outside of the United States
Johns Hopkins Kimmel Cancer Center - Green Spring Station
Appointment Phone: 410-583-2970
10753 Falls Road
Pavillion II Suite 415
Lutherville, MD 21093 map
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Appointment Phone: 410-955-8964
401 N. Broadway
Weinberg Building Suite 1100
Baltimore, MD 21231 map
John Fetting, a 30-year veteran of the Johns Hopkins faculty, readily discusses the dramatic changes in the treatment of breast cancer that have evolved during his tenure, such as how clinicians now choose a treatment protocol based on the biological characteristics of the cancer as opposed to a patient’s menopausal status. But he’s more interested in addressing what hasn’t yet happened in breast cancer prevention.
“We are not any closer to “actionable” prevention than when I started my career,” Dr. Fetting says.
He explains that while some risk factors have been identified, such as having a first pregnancy at or after age 30, they don’t represent someone at high risk. “Most women with these risk factors are not going to get breast cancer. Other than women who carry an inherited mutation, which increases risk, we just don’t have a good idea of who is at sufficient risk for breast cancer to drive action,” Dr. Fetting says.
It’s a reality he is not willing to accept.
“Now that we can sequence the breast cancer genome, we are identifying mutations which can be the targets for treatment. Why can’t we identify genetic changes in normal breast cells which indicate that these cells will develop breast cancer? If we could, we might be able to identify women at sufficient risk to merit intervention. We might also be able to reassure a lot of women who don’t possess these changes in their breasts that they are not at risk,” Dr. Fetting says.
That’s why, as he enters the final years of his career, Dr. Fetting is embarking on a fundraising crusade to support of breast cancer prevention research at Hopkins. The John Fetting Fund for Breast Cancer Prevention Research was initiated by one of his patient’s, Leslie Ries, and her husband, Tom. The five-year goal of the recently-initiated fund is $5 million dollars.
Encouraged by the field’s vastly increased understanding of the biology of breast cancer, Dr. Fetting expects these advancements to be successfully applied to prevention if the research is adequately supported. “There is strong support for research on cancer treatment. Support for prevention research is much harder to come by. Philanthropy can enable us to take advantage of the tremendous prevention opportunities presented to us by our rapidly increasing understanding of the breast cancer genome and epigenome,” he says.
- Associate Director for Clinical Practice
- Associate Professor of Oncology
- Assistant Professor of Psychiatry and Behavioral Sciences
- Associate Professor of Medicine
Centers & Institutes
- MD, Johns Hopkins University School of Medicine (1975)
- Johns Hopkins University School of Medicine / Medicine (1977)
- Massachusetts General Hospital / Psychiatry (1980)
- American Board of Internal Medicine / Internal Medicine (1979)
- American Board of Internal Medicine / Medical Oncology (1983)
- American Board of Psychiatry & Neurology / Psychiatry (1981)
Research & Publications
Clinical Trial KeywordsBreast cancer
Activities & Honors
- Inducted Member, The Miller-Coulson Academy of Clinical Excellence, 2015